Oger competitive analysis

Explore patent oppositions filed by Oger against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 19, 2026
Patent NumberTitleApplicantOpposition Date
Normalization And Baseline Shift Removal For Nanopore-Sbs SignalsF HOFFMANN LA ROCHENov 9, 2026
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSNov 4, 2026
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSSep 10, 2026
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSSep 10, 2026
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSSep 10, 2026
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSAug 19, 2026
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSFeb 20, 2026
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNAAug 20, 2025
Nucleic Acid VaccinesMODERNAJul 9, 2025
Charged Depth Filtration Of Antigen-Binding ProteinsAMGENMay 7, 2025

Latest PTAB cases involving Oger

Discover the latest PTAB cases involving Oger, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Oger with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 19, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
WITHERS & ROGERS38 - - -
F HOFFMANN LA ROCHE34238 - -
MODERNA57512
TRANSLATE BIO - 28 - -